Annual CFO
-$23.08 M
-$32.44 M-346.62%
31 December 2023
Summary:
TherapeuticsMD annual cash flow from operations is currently -$23.08 million, with the most recent change of -$32.44 million (-346.62%) on 31 December 2023. During the last 3 years, it has risen by +$136.39 million (+85.53%). TXMD annual CFO is now -346.62% below its all-time high of $9.36 million, reached on 31 December 2022.TXMD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$71.00 K
-$1.52 M-104.89%
30 September 2024
Summary:
TherapeuticsMD quarterly cash flow from operations is currently -$71.00 thousand, with the most recent change of -$1.52 million (-104.89%) on 30 September 2024. Over the past year, it has increased by +$5.96 million (+98.82%). TXMD quarterly CFO is now -100.23% below its all-time high of $30.24 million, reached on 31 December 2022.TXMD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$3.81 M
+$5.96 M+61.01%
30 September 2024
Summary:
TherapeuticsMD TTM cash flow from operations is currently -$3.81 million, with the most recent change of +$5.96 million (+61.01%) on 30 September 2024. Over the past year, it has dropped by -$15.92 million (-131.42%). TXMD TTM CFO is now -110.62% below its all-time high of $35.86 million, reached on 30 June 2023.TXMD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -346.6% | +98.8% | -131.4% |
| 3 y3 years | +85.5% | +99.8% | +97.2% |
| 5 y5 years | +78.4% | +99.7% | +97.3% |
TXMD Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -346.6% | +85.5% | -100.2% | +99.8% | -110.6% | +97.3% |
| 5 y | 5 years | -346.6% | +86.1% | -100.2% | +99.9% | -110.6% | +97.9% |
| alltime | all time | -346.6% | +86.1% | -100.2% | +99.9% | -110.6% | +97.9% |
TherapeuticsMD Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$71.00 K(-104.9%) | -$3.81 M(-61.0%) |
| June 2024 | - | $1.45 M(-734.5%) | -$9.76 M(-33.2%) |
| Mar 2024 | - | -$229.00 K(-95.4%) | -$14.61 M(-36.7%) |
| Dec 2023 | -$23.08 M(-346.6%) | -$4.96 M(-17.7%) | -$23.08 M(-290.5%) |
| Sept 2023 | - | -$6.03 M(+77.7%) | $12.12 M(-66.2%) |
| June 2023 | - | -$3.39 M(-61.0%) | $35.86 M(+93.5%) |
| Mar 2023 | - | -$8.70 M(-128.8%) | $18.53 M(+98.0%) |
| Dec 2022 | $9.36 M(-106.6%) | $30.24 M(+70.7%) | $9.36 M(-115.5%) |
| Sept 2022 | - | $17.72 M(-185.5%) | -$60.44 M(-48.1%) |
| June 2022 | - | -$20.72 M(+15.9%) | -$116.37 M(-4.8%) |
| Mar 2022 | - | -$17.87 M(-54.8%) | -$122.19 M(-14.4%) |
| Dec 2021 | -$142.69 M(-10.5%) | -$39.56 M(+3.5%) | -$142.69 M(+6.9%) |
| Sept 2021 | - | -$38.22 M(+44.1%) | -$133.49 M(+3.2%) |
| June 2021 | - | -$26.53 M(-30.9%) | -$129.32 M(-18.5%) |
| Mar 2021 | - | -$38.38 M(+26.4%) | -$158.74 M(-0.5%) |
| Dec 2020 | -$159.47 M(-3.8%) | -$30.36 M(-10.8%) | -$159.47 M(-11.4%) |
| Sept 2020 | - | -$34.05 M(-39.1%) | -$179.93 M(+4.5%) |
| June 2020 | - | -$55.95 M(+43.1%) | -$172.11 M(+3.3%) |
| Mar 2020 | - | -$39.11 M(-23.0%) | -$166.67 M(+0.6%) |
| Dec 2019 | -$165.72 M(+55.1%) | -$50.82 M(+93.8%) | -$165.72 M(+15.9%) |
| Sept 2019 | - | -$26.22 M(-48.1%) | -$143.05 M(-5.2%) |
| June 2019 | - | -$50.51 M(+32.4%) | -$150.89 M(+20.4%) |
| Mar 2019 | - | -$38.16 M(+35.6%) | -$125.33 M(+17.3%) |
| Dec 2018 | -$106.81 M(+40.3%) | -$28.14 M(-17.4%) | -$106.81 M(+7.4%) |
| Sept 2018 | - | -$34.07 M(+36.5%) | -$99.47 M(+21.2%) |
| June 2018 | - | -$24.95 M(+27.0%) | -$82.09 M(+9.0%) |
| Mar 2018 | - | -$19.65 M(-5.6%) | -$75.28 M(-1.2%) |
| Dec 2017 | -$76.16 M(+10.1%) | -$20.81 M(+24.7%) | -$76.16 M(+7.3%) |
| Sept 2017 | - | -$16.68 M(-8.0%) | -$70.97 M(-2.9%) |
| June 2017 | - | -$18.14 M(-11.6%) | -$73.08 M(+4.0%) |
| Mar 2017 | - | -$20.53 M(+31.4%) | -$70.26 M(+1.6%) |
| Dec 2016 | -$69.14 M(-12.5%) | -$15.62 M(-16.9%) | -$69.14 M(-1.4%) |
| Sept 2016 | - | -$18.80 M(+22.7%) | -$70.13 M(+0.5%) |
| June 2016 | - | -$15.32 M(-21.0%) | -$69.77 M(-12.0%) |
| Mar 2016 | - | -$19.40 M(+16.8%) | -$79.30 M(+0.3%) |
| Dec 2015 | -$79.04 M(+73.6%) | -$16.61 M(-9.9%) | -$79.04 M(+1.7%) |
| Sept 2015 | - | -$18.44 M(-25.8%) | -$77.72 M(+9.9%) |
| June 2015 | - | -$24.85 M(+29.8%) | -$70.74 M(+26.4%) |
| Mar 2015 | - | -$19.15 M(+25.3%) | -$55.96 M(+22.9%) |
| Dec 2014 | -$45.52 M(+119.2%) | -$15.29 M(+33.4%) | -$45.52 M(+30.0%) |
| Sept 2014 | - | -$11.46 M(+13.8%) | -$35.00 M(+21.3%) |
| June 2014 | - | -$10.07 M(+15.7%) | -$28.86 M(+11.2%) |
| Mar 2014 | - | -$8.71 M(+82.6%) | -$25.97 M(+25.0%) |
| Dec 2013 | -$20.77 M(+63.0%) | -$4.77 M(-10.3%) | -$20.77 M(+3.8%) |
| Sept 2013 | - | -$5.31 M(-25.9%) | -$20.01 M(+12.6%) |
| June 2013 | - | -$7.18 M(+104.5%) | -$17.77 M(+28.8%) |
| Mar 2013 | - | -$3.51 M(-12.4%) | -$13.79 M(+8.3%) |
| Dec 2012 | -$12.74 M(+156.5%) | -$4.01 M(+30.0%) | -$12.74 M(+20.0%) |
| Sept 2012 | - | -$3.08 M(-3.6%) | -$10.62 M(+17.2%) |
| June 2012 | - | -$3.20 M(+30.4%) | -$9.05 M(+36.0%) |
| Mar 2012 | - | -$2.45 M(+30.1%) | -$6.66 M(+34.1%) |
| Dec 2011 | -$4.97 M | -$1.88 M(+24.0%) | -$4.97 M(-28.9%) |
| Sept 2011 | - | -$1.52 M(+89.5%) | -$6.99 M(+61.6%) |
| June 2011 | - | -$801.80 K(+5.4%) | -$4.32 M(+25.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$760.70 K(-80.5%) | -$3.46 M(+21.6%) |
| Dec 2010 | -$2.84 M(+581.5%) | -$3.90 M(-441.7%) | -$2.84 M(-408.2%) |
| Sept 2010 | - | $1.14 M(+1671.0%) | $922.80 K(-303.3%) |
| June 2010 | - | $64.50 K(-143.7%) | -$454.00 K(-15.7%) |
| Mar 2010 | - | -$147.50 K(+8.1%) | -$538.40 K(+29.0%) |
| Dec 2009 | -$417.30 K(+213.8%) | -$136.50 K(-41.8%) | -$417.40 K(+43.8%) |
| Sept 2009 | - | -$234.50 K(+1078.4%) | -$290.30 K(+155.8%) |
| June 2009 | - | -$19.90 K(-24.9%) | -$113.50 K(-25.2%) |
| Mar 2009 | - | -$26.50 K(+181.9%) | -$151.80 K(+14.2%) |
| Dec 2008 | -$133.00 K(-138.7%) | -$9400.00(-83.7%) | -$132.90 K(-1114.5%) |
| Sept 2008 | - | -$57.70 K(-0.9%) | $13.10 K(-93.1%) |
| June 2008 | - | -$58.20 K(+665.8%) | $190.20 K(-31.8%) |
| Mar 2008 | - | -$7600.00(-105.6%) | $278.90 K(-18.9%) |
| Dec 2007 | $344.10 K(+4.3%) | $136.60 K(+14.4%) | $344.00 K(+55.8%) |
| Sept 2007 | - | $119.40 K(+291.5%) | $220.80 K(-24.1%) |
| June 2007 | - | $30.50 K(-47.0%) | $290.80 K(-5.4%) |
| Mar 2007 | - | $57.50 K(+329.1%) | $307.30 K(-6.9%) |
| Dec 2006 | $329.80 K(-20.0%) | $13.40 K(-92.9%) | $329.90 K(-27.4%) |
| Sept 2006 | - | $189.40 K(+303.0%) | $454.20 K(+6.9%) |
| June 2006 | - | $47.00 K(-41.3%) | $424.80 K(+10.2%) |
| Mar 2006 | - | $80.10 K(-41.8%) | $385.40 K(-6.5%) |
| Dec 2005 | $412.30 K(+98.5%) | $137.70 K(-13.9%) | $412.30 K(+24.2%) |
| Sept 2005 | - | $160.00 K(+2005.3%) | $331.90 K(+32.0%) |
| June 2005 | - | $7600.00(-92.9%) | $251.50 K(-16.3%) |
| Mar 2005 | - | $107.00 K(+86.7%) | $300.40 K(+44.6%) |
| Dec 2004 | $207.70 K(+48.4%) | $57.30 K(-28.0%) | $207.70 K(+5.2%) |
| Sept 2004 | - | $79.60 K(+40.9%) | $197.40 K(+28.9%) |
| June 2004 | - | $56.50 K(+295.1%) | $153.20 K(+34.9%) |
| Mar 2004 | - | $14.30 K(-69.6%) | $113.60 K(-18.9%) |
| Dec 2003 | $140.00 K(+39.9%) | $47.00 K(+32.8%) | $140.00 K(+4.2%) |
| Sept 2003 | - | $35.40 K(+109.5%) | $134.30 K(+13.1%) |
| June 2003 | - | $16.90 K(-58.5%) | $118.70 K(-4.5%) |
| Mar 2003 | - | $40.70 K(-1.5%) | $124.30 K(+24.2%) |
| Dec 2002 | $100.10 K(-38.2%) | $41.30 K(+108.6%) | $100.10 K(+88.2%) |
| Sept 2002 | - | $19.80 K(-12.0%) | $53.20 K(-32.6%) |
| June 2002 | - | $22.50 K(+36.4%) | $78.90 K(-39.9%) |
| Mar 2002 | - | $16.50 K(-394.6%) | $131.20 K(-19.0%) |
| Dec 2001 | $161.90 K(+20.8%) | -$5600.00(-112.3%) | $162.00 K(-26.0%) |
| Sept 2001 | - | $45.50 K(-39.2%) | $219.00 K(+1.8%) |
| June 2001 | - | $74.80 K(+58.1%) | $215.10 K(+35.4%) |
| Mar 2001 | - | $47.30 K(-8.0%) | $158.90 K(+18.6%) |
| Dec 2000 | $134.00 K(+176.3%) | $51.40 K(+23.6%) | $134.00 K(+3.4%) |
| Sept 2000 | - | $41.60 K(+123.7%) | $129.60 K(+77.8%) |
| June 2000 | - | $18.60 K(-17.0%) | $72.90 K(+32.1%) |
| Mar 2000 | - | $22.40 K(-52.3%) | $55.20 K(+13.8%) |
| Dec 1999 | $48.50 K(+8.7%) | $47.00 K(-411.3%) | $48.50 K(+3133.3%) |
| Sept 1999 | - | -$15.10 K(-1777.8%) | $1500.00(-91.0%) |
| June 1999 | - | $900.00(-94.3%) | $16.60 K(+5.7%) |
| Mar 1999 | - | $15.70 K | $15.70 K |
| Dec 1998 | $44.60 K(-42.5%) | - | - |
| Dec 1997 | $77.50 K(+31.8%) | - | - |
| Dec 1996 | $58.80 K(-7.3%) | - | - |
| Dec 1995 | $63.40 K(-13.0%) | - | - |
| Dec 1994 | $72.90 K(+21.9%) | - | - |
| Dec 1993 | $59.80 K | - | - |
FAQ
- What is TherapeuticsMD annual cash flow from operations?
- What is the all time high annual CFO for TherapeuticsMD?
- What is TherapeuticsMD annual CFO year-on-year change?
- What is TherapeuticsMD quarterly cash flow from operations?
- What is the all time high quarterly CFO for TherapeuticsMD?
- What is TherapeuticsMD quarterly CFO year-on-year change?
- What is TherapeuticsMD TTM cash flow from operations?
- What is the all time high TTM CFO for TherapeuticsMD?
- What is TherapeuticsMD TTM CFO year-on-year change?
What is TherapeuticsMD annual cash flow from operations?
The current annual CFO of TXMD is -$23.08 M
What is the all time high annual CFO for TherapeuticsMD?
TherapeuticsMD all-time high annual cash flow from operations is $9.36 M
What is TherapeuticsMD annual CFO year-on-year change?
Over the past year, TXMD annual cash flow from operations has changed by -$32.44 M (-346.62%)
What is TherapeuticsMD quarterly cash flow from operations?
The current quarterly CFO of TXMD is -$71.00 K
What is the all time high quarterly CFO for TherapeuticsMD?
TherapeuticsMD all-time high quarterly cash flow from operations is $30.24 M
What is TherapeuticsMD quarterly CFO year-on-year change?
Over the past year, TXMD quarterly cash flow from operations has changed by +$5.96 M (+98.82%)
What is TherapeuticsMD TTM cash flow from operations?
The current TTM CFO of TXMD is -$3.81 M
What is the all time high TTM CFO for TherapeuticsMD?
TherapeuticsMD all-time high TTM cash flow from operations is $35.86 M
What is TherapeuticsMD TTM CFO year-on-year change?
Over the past year, TXMD TTM cash flow from operations has changed by -$15.92 M (-131.42%)